Tesofensine and optically active acetylamino acid salts, use thereof in the treatment and/or prevention of disorders related to obesity
EA026727B1
Salt of (1r,2r,3s)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane and phthalic acid, method for production thereof, product of the method, pharmaceutical compositions for treatment and/or prophylaxis of disorders associated with obesity, use thereof and methods for treatment and/or prophylaxis of disorders associated with obesity
EA025549B1
Composition and agents for prevention and treatment of diseases of the joints and the spine, and methods of their application
WO2014162190A2
Peptides with cytoprotective activity
EA022732B1
Pharmaceutical composition and set for prevention and treatment of disorders, associated with excessive weight or obesity, use thereof and method for prevention and treatment of disorders, associated with excessive weight or obesity
EA023025B1
Pharmaceutical composition having a neuroprotective effect, use thereof and methods for enhancing vitality and preventing and/or treating cerebrovascular and neurodegenerative diseases
EA023136B1
Pharmaceutical composition possessing pancreoprotective activity, use thereof for prevention and/or treatment of pancreatitis and method for prevention and treatment of pancreatitis
EP2921176A2
Pharmaceutical composition for treatment of prostatic hyperplasia
EA020800B1
Pharmaceutical composition having a neuroprotective, nootropic, antiamnesic effect, and method for preventing and/or treating states associated with cerebral circulation disorders, cerebrovascular and neurodegenerative diseases
